• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    7/24/23 2:54:54 PM ET
    $AMC
    $APLD
    $APPH
    $ARMP
    Movies/Entertainment
    Consumer Discretionary
    Finance: Consumer Services
    Finance
    Get the next $AMC alert in real time by email

    Gainers

    • Tupperware Brands Corporation (NYSE:TUP) shares jumped 59% to $1.43 on above-average volume amid retail investor interest.
    • Vinco Ventures, Inc. (NASDAQ:BBIG) gained 51.4% to $5.04.
    • Spark Networks SE (NYSE:LOV) jumped 25.5% to $0.2862.
    • AMC Entertainment Holdings, Inc. (NYSE:AMC) shares surged 25% to $5.51 after a Delaware judge denied the company from converting its AMC preferred equity units into common stock.
    • Applied Digital Corporation (NASDAQ:APLD) gained 23.4% to $9.53 after the company reported better-than-expected fourth-quarter adjusted EPS results and issued FY24 revenue guidance above estimates.
    • BioNexus Gene Lab Corp. (NASDAQ:BGLC) shares rose 22.2% to $5.95 after gaining 22% on Friday.
    • Knightscope, Inc. (NASDAQ:KSCP) gained 21.6% to $1.4593. Knightscope received letter of compliance from the Nasdaq.
    • Superior Drilling Products, Inc. (NYSE:SDPI) jumped 20.8% to $2.1750.
    • Jaguar Health, Inc. (NASDAQ:JAGX) gained 19.6% to $0.67.
    • Steakholder Foods Ltd. (NASDAQ:STKH) rose 19% to $1.00. Steakholder Foods Ltd entered into a Memorandum of Agreement for Strategic Cooperation (MOA) with an accredited GCC-based governmental body as its strategic partner.
    • Marker Therapeutics, Inc. (NASDAQ:MRKR) gained 18.6% to $7.84.
    • Armata Pharmaceuticals, Inc. (NYSE:ARMP) shares gained 17.4% to $1.35.
    • Koss Corporation (NASDAQ:KOSS) shares gained 17.3% to $4.24.
    • POSCO Holdings Inc. (NYSE:PKX) shares gained 17.2% to $124.43 following strong quarterly earnings.
    • HighPeak Energy, Inc. (NASDAQ:HPK) rose 16% to $15.02.
    • PaxMedica, Inc. (NASDAQ:PXMD) jumped 16% to $0.9382 after the company reported topline results from PAX-101 (intravenous suramin) Phase 3 African sleeping sickness study.
    • Educational Development Corporation (NASDAQ:EDUC) surged 16% to $1.8011.
    • Dragonfly Energy Holdings Corp. (NASDAQ:DFLI) gained 14.6% to $2.8599.
    • NIO Inc. (NYSE:NIO) jumped 12.5% to $11.91. Shares of several Chinese companies traded higher after China earlier announced it has pledged to optimize the business environment for private enterprises ahead of the Politburo meeting later this week.
    • Yellow Corporation (NASDAQ:YELL) jumped 12.2% to $1.1899.
    • Metropolitan Bank Holding Corp. (NYSE:MCB) gained 8.6% to $45.46. Metropolitan Bank Holding recently reported worse-than-expected second-quarter financial results.
    • Becton, Dickinson and Company (NYSE:BDX) rose 6.2% to $281.35 after the company announced it received FDA510(k) clearance for the updated BD Alaris Infusion System. Also, Raymond James upgraded the stock from Market Perform to Outperform with a $305 price target.

    Losers

    • AppHarvest, Inc. (NASDAQ:APPH) shares fell 69.9% to $0.1009. AppHarvest announced Chapter 11 filing to support a financial and operational transition.
    • Kodiak Sciences Inc. (NASDAQ:KOD) fell 47.7% to $3.8215 after the company released topline results from three Phase 3 studies of tarcocimab tedromer for neovascular age-related macular degeneration and diabetic macular edema.
    • BioCardia, Inc (NASDAQ:BCDA) declined 44.4% to $1.1001.
    • 22nd Century Group, Inc. (NYSE:XXII) fell 43.1% to $2.7583. 22nd Century named interim CEO and implemented a $15 million cost reduction initiative.
    • ViewRay, Inc. (NASDAQ:VRAY) fell 28.6% to $0.0421 after the company reported commencement of Nasdaq delisting proceedings. The company’s common stock is expected to begin trading on the over-the counter markets.
    • Contango Ore, Inc. (NYSE:CTGO) fell 27.1% to $19.33 after the company reported an underwritten public offering of common stock.
    • Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) shares fell 39.5% to $0.1337 MEI Pharma failed to secure stockholder approval for the merger deal with Infinity Pharmaceuticals.
    • Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) fell 30.1% to $5.18 after the company announced non-binding term sheet for up to $125 million debt financing.
    • Quince Therapeutics, Inc. (NASDAQ:QNCX) fell 26.9% to $1.1550. Quince Therapeutics agreed to acquire EryDel SpA, a privately-held, late-stage biotech company, in a stock-for-stock upfront exchange and potential downstream milestone cash payments.
    • Guardforce AI Co., Limited (NASDAQ:GFAI) declined 25.7% to $6.24.
    • Carmell Therapeutics Corporation (NASDAQ:CTCX) fell 22% to $4.2850.
    • TMC the metals company Inc. (NASDAQ:TMC) fell 21.7% to $1.4250.
    • DarioHealth Corp. (NASDAQ:DRIO) fell 17.1% to $3.5050 after the company reported preliminary second-quarter preliminary revenue results below the estimate.
    • Lifezone Metals Limited (NYSE:LZM) declined 16.2% to $9.05.
    • Stoke Therapeutics, Inc. (NASDAQ:STOK) fell 16% to $10.08
    • Digital World Acquisition Corp. (NASDAQ:DWAC) shares fell 15.1% to $17.05. Digital World Acquisition shares jumped over 50% on Friday after the company announced it reached a settlement with the SEC.
    • Biomea Fusion, Inc. (NASDAQ:BMEA) declined 14.7% to $18.37 as the company released preliminary topline data from its ongoing Phase 1 COVALENT-101 trial, showcasing initial responses in relapsed/refractory AML patients with menin-dependent mutations.
    • INVO Bioscience, Inc. (NASDAQ:INVO) fell 14.4% to $0.1420.
    • Liquidia Corporation (NASDAQ:LQDA) declined 13.8% to $7.03.
    • PSQ Holdings, Inc. (NYSE:PSQH) fell 12.4% to $18.50 after declining 29% on Friday. Trading of PublicSq.'s shares of Class A common stock commencedThursday following the successful completion of its previously announced business combination with Colombier Acquisition Corp.
    • Camber Energy, Inc. (NYSE:CEI) shares fell 11.6% to $1.0787. Camber Energy shares gained 53% on Friday after the company and Viking Energy announced shareholder approval of the merger.
    • ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) fell 9.9% to $0.1788 as the company announces pricing of $2.1 million public offering of 12,727,273 shares of common stock and warrants at a price of $0.165 per unit.
    • fuboTV Inc. (NASDAQ:FUBO) fell 9.6% to $2.4950.
    • E-Home Household Service Holdings Limited (NASDAQ:EJH) fell 9% to $0.1146.
    • Ryanair Holdings plc (NASDAQ:RYAAY) fell 8.3% to $98.59 after the company reported quarterly results.

     

    Now Read This: Check Out 3 High-Yielding Dividend Stocks In Tech And Telecom Sector From Wall Street's Most Accurate Analysts

    Get the next $AMC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMC
    $APLD
    $APPH
    $ARMP

    CompanyDatePrice TargetRatingAnalyst
    HighPeak Energy Inc.
    $HPK
    10/14/2025$12.00Buy
    Roth Capital
    Becton Dickinson and Company
    $BDX
    9/25/2025$211.00Sector Perform
    RBC Capital Mkts
    Kodiak Sciences Inc
    $KOD
    9/25/2025$17.00Underweight → Equal Weight
    Barclays
    NIO Inc.
    $NIO
    9/23/2025$8.10 → $8.60Buy
    Citigroup
    Kodiak Sciences Inc
    $KOD
    9/22/2025$15.00Buy
    Jefferies
    NIO Inc.
    $NIO
    9/16/2025$8.50Neutral → Buy
    UBS
    Applied Digital Corporation
    $APLD
    9/15/2025Buy
    Compass Point
    Ryanair Holdings plc
    $RYAAY
    9/8/2025Buy → Neutral
    Goldman
    More analyst ratings

    $AMC
    $APLD
    $APPH
    $ARMP
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for YCANTH issued to VERRICA PHARMACEUTICALS INC

    Submission status for VERRICA PHARMACEUTICALS INC's drug YCANTH (ORIG-1) with active ingredient CANTHARIDIN has changed to 'Approval' on 07/21/2023. Application Category: NDA, Application Number: 212905, Application Classification: Type 5 - New Formulation or New Manufacturer

    7/21/23 4:54:32 PM ET
    $VRCA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    November 23, 2021 - Coronavirus (COVID-19) Update: November 23, 2021

    For Immediate Release: November 23, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On Nov. 22, the FDA authorized three over-the-counter (OTC) COVID-19 antigen diagnostic tests for people age 14 years or older with a self-collected nasal swab sample or people age 2 years or older when an adult collects the nasal swa

    11/23/21 3:16:12 PM ET
    $BDX
    Medical/Dental Instruments
    Health Care

    $AMC
    $APLD
    $APPH
    $ARMP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Stertzer Simon H bought $498,000 worth of shares (398,400 units at $1.25) (SEC Form 4)

    4 - BioCardia, Inc. (0000925741) (Issuer)

    9/23/25 9:00:48 AM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Blank Andrew Scott bought $360,000 worth of shares (288,000 units at $1.25) (SEC Form 4)

    4 - BioCardia, Inc. (0000925741) (Issuer)

    9/23/25 9:00:29 AM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    President and CEO Altman Peter bought $60,000 worth of shares (48,000 units at $1.25), increasing direct ownership by 28% to 216,762 units (SEC Form 4)

    4 - BioCardia, Inc. (0000925741) (Issuer)

    9/23/25 9:00:09 AM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AMC
    $APLD
    $APPH
    $ARMP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital resumed coverage on HighPeak Energy with a new price target

    Roth Capital resumed coverage of HighPeak Energy with a rating of Buy and set a new price target of $12.00

    10/14/25 8:50:01 AM ET
    $HPK
    Oil & Gas Production
    Energy

    RBC Capital Mkts initiated coverage on Becton Dickinson with a new price target

    RBC Capital Mkts initiated coverage of Becton Dickinson with a rating of Sector Perform and set a new price target of $211.00

    9/25/25 8:27:46 AM ET
    $BDX
    Medical/Dental Instruments
    Health Care

    Kodiak Sciences upgraded by Barclays with a new price target

    Barclays upgraded Kodiak Sciences from Underweight to Equal Weight and set a new price target of $17.00

    9/25/25 8:23:23 AM ET
    $KOD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AMC
    $APLD
    $APPH
    $ARMP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kaye Edward M. Md sold $750,000 worth of shares (25,000 units at $30.00) and exercised 25,000 shares at a strike of $0.60 (SEC Form 4)

    4 - Stoke Therapeutics, Inc. (0001623526) (Issuer)

    10/10/25 4:12:24 PM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Mohmand Mohammad Saidal Lavanway converted options into 94,167 shares and covered exercise/tax liability with 37,055 shares, increasing direct ownership by 28% to 258,912 units (SEC Form 4)

    4 - Applied Digital Corp. (0001144879) (Issuer)

    10/7/25 4:33:00 PM ET
    $APLD
    Finance: Consumer Services
    Finance

    Director Kaye Edward M. Md sold $1,065,206 worth of shares (42,461 units at $25.09), decreasing direct ownership by 46% to 49,124 units (SEC Form 4)

    4 - Stoke Therapeutics, Inc. (0001623526) (Issuer)

    10/7/25 4:26:59 PM ET
    $STOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMC
    $APLD
    $APPH
    $ARMP
    SEC Filings

    View All

    SEC Form 6-K filed by POSCO HOLDINGS INC.

    6-K - POSCO HOLDINGS INC. (0000889132) (Filer)

    10/14/25 8:00:59 AM ET
    $PKX
    Steel/Iron Ore
    Industrials

    SEC Form 6-K filed by Ryanair Holdings plc

    6-K - RYANAIR HOLDINGS PLC (0001038683) (Filer)

    10/14/25 6:11:25 AM ET
    $RYAAY
    Air Freight/Delivery Services
    Consumer Discretionary

    Dragonfly Energy Holdings Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Dragonfly Energy Holdings Corp. (0001847986) (Filer)

    10/14/25 6:03:39 AM ET
    $DFLI
    Industrial Machinery/Components
    Miscellaneous

    $AMC
    $APLD
    $APPH
    $ARMP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Knightscope Surpasses Yet Another $1M Milestone in New Sales Won and Renewals

    Knightscope, Inc. (NASDAQ:KSCP), a leader in autonomous security robots and emergency communication devices, on the heels of announcing $1 million last month and months prior, today announced that it has exceeded yet an additional $1 million in new contracts and renewals, reinforcing its strong market momentum. The surge reflects a growing commitment among organizations nationwide to adopt advanced, technology-driven solutions that enhance safety, strengthen security infrastructure, and modernize public and private environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251014825428/en/ Emergency Communication Device (ECD)

    10/14/25 9:20:00 AM ET
    $KSCP
    Telecommunications Equipment
    Telecommunications

    Armata Pharmaceuticals to Present Late-Breaking Clinical Data highlighting its Staphylococcus aureus Bacteriophage Cocktail, AP-SA02, at IDWeek 2025™

    LOS ANGELES, Oct. 14, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE:ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections, today announced it will be presenting late-breaking Phase 2a clinical data on its Staphylococcus aureus bacteriophage cocktail, AP-SA02, at IDWeek 2025™, which is being held October 19-22, 2025, in Atlanta, GA. Details of the oral presentation are as follo

    10/14/25 7:00:00 AM ET
    $ARMP
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Dario Signs 6 New Employer Clients Representing Tens of Thousands of Lives Deepening its Leadership in Value-Based Care

    New clients span multiple industries and underscore broad increasing demand for Dario's multi-condition digital health platform Innovative new pricing model is highly attractive to prospective clients – supports Dario's continued market momentum and leading position as value-based solution provider NEW YORK, Oct. 13, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ:DRIO) ("Dario" or the "Company"), a leader in the global digital health market, today announced the addition of six (6) new employer clients to its growing portfolio, underscoring accelerating demand for integrated, multi-condition digital health solutions that improve health and reduce costs, as well as the deployment of a new pri

    10/13/25 8:30:00 AM ET
    $DRIO
    Medical/Dental Instruments
    Health Care

    $AMC
    $APLD
    $APPH
    $ARMP
    Leadership Updates

    Live Leadership Updates

    View All

    HighPeak Energy, Inc. Announces CEO Transition

    FORT WORTH, Texas, Sept. 16, 2025 (GLOBE NEWSWIRE) -- HighPeak Energy, Inc. ("HighPeak" or the "Company") (NASDAQ:HPK) today announced that the Board of Directors (the "Board") and Mr. Jack Hightower, current Chief Executive Officer and Chairman of the Board, have agreed that Mr. Hightower will retire from his positions with the Company, including as Chief Executive Officer, a director and Chairman of the Board. The Company also announced that Michael L. Hollis, current President of the Company and a member of the Board, has been appointed Interim Chief Executive Officer of the Company, effective immediately. Mr. Hollis has served as President of HighPeak and a member of the Board since

    9/16/25 5:50:00 AM ET
    $FANG
    $HPK
    Oil & Gas Production
    Energy

    PublicSquare to Host Virtual Analyst & Investor Day on Thursday, September 25, 2025

    PSQ Holdings, Inc. (NYSE:PSQH) ("PublicSquare" or the "Company") announced today that the Company will host a virtual analyst and investor day on Thursday, September 25, 2025 from 11:00 a.m. ET to 1:00 p.m. ET. The Company will post slides and other supporting material to its website on the day of the event. Michael Siefert, Chief Executive Officer, Dusty Wunderlich, Chief Strategy Officer and other members of the executive leadership team will discuss strategic fintech initiatives, long-term plans related to digital assets, and business outlook followed by an interactive question-and-answer session. The analyst and investor day will be broadcast live through a link on the PublicSquare

    9/3/25 7:00:00 AM ET
    $PSQH
    Advertising
    Consumer Discretionary

    BD Expands Peripheral Artery Disease Awareness Efforts with 'Love Your Limbs' Community Screening Initiative

    FRANKLIN LAKES, N.J., Sept. 2, 2025 /PRNewswire/ -- In recognition of Peripheral Artery Disease (PAD) Awareness Month, BD (Becton, Dickinson and Company) (NYSE:BDX) is shining a spotlight on a serious yet often overlooked circulatory disorder that restricts blood flow to the limbs and is a leading cause of preventable amputations. https://loveyourlimbs.com to learn more or get involved." alt="September is Peripheral Artery Disease Awareness Month. Visit https://loveyourlimbs.com to learn more or get involved."> PAD affects more than 21 million Americans1 and more than 200 milli

    9/2/25 6:50:00 AM ET
    $BDX
    Medical/Dental Instruments
    Health Care

    $AMC
    $APLD
    $APPH
    $ARMP
    Financials

    Live finance-specific insights

    View All

    Dragonfly Energy Announces Third Quarter 2025 Select Preliminary Results

    Preliminary Third Quarter Net Sales and Adjusted EBITDA Exceeded our Guidance Preliminary Third Quarter Net Sales Represent 26% Year over Year Growth RENO, Nev., Oct. 13, 2025 (GLOBE NEWSWIRE) -- Dragonfly Energy Holdings Corp. ("Dragonfly Energy" or the "Company") (NASDAQ:DFLI), an industry leader in energy storage and battery technology, today announced preliminary third quarter 2025 Net Sales and Adjusted EBITDA. The Company anticipates third quarter 2025 Net Sales of $16.0 million and Adjusted EBITDA of $(2.2) million, above guidance of $15.9 million for Net Sales and above guidance of $(2.7) million for Adjusted EBITDA. Anticipated results represent 26% year-over-year growth in Net

    10/13/25 7:30:00 AM ET
    $DFLI
    Industrial Machinery/Components
    Miscellaneous

    Biomea Fusion Announces Positive 52-Week Results from Phase II COVALENT-111 Study in Type 2 Diabetes Demonstrating Non-Chronic Treatment with Icovamenib Benefits Two Distinct Patient Populations

    Icovamenib showed a sustained treatment benefit at Week 52 (9 months past the end of treatment) in the severe insulin-deficient diabetes patient population taking one or more antihyperglycemic medications at baseline, with a 1.8% placebo adjusted mean reduction in HbA1c (Arm B)Type 2 diabetes patients on a GLP-1-based therapy failing to achieve their target HbA1c also showed a clinically meaningful response from only 12 weeks of icovamenib treatment with a mean placebo adjusted HbA1c reduction of 1.8% (Arms A, B, and C combined) at Week 52Icovamenib was generally well tolerated across all dosing arms and demonstrated a favorable safety and tolerability profile through Week 52 Phase II trials

    10/6/25 4:03:07 PM ET
    $BMEA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Metropolitan Bank Holding Corp. Announces Third Quarter 2025 Earnings Release and Conference Call Date

    Metropolitan Bank Holding Corp. (the "Company") (NYSE:MCB), the holding company for Metropolitan Commercial Bank, today announced it will release third quarter 2025 financial results after the market closes on Thursday, October 23, 2025. The Company will conduct a conference call at 9:00 a.m. ET on Friday, October 24, 2025, to discuss the results. To access the event by telephone, please dial 800-245-3047 (US), 203-518-9765 (INTL), and provide conference ID: MCBQ325 approximately 15 minutes prior to the start time (to allow time for registration). The call will also be broadcast live over the Internet and accessible at MCB Quarterly Results Conference Call and in the Investor Relations

    10/3/25 2:47:00 PM ET
    $MCB
    Major Banks
    Finance

    $AMC
    $APLD
    $APPH
    $ARMP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by DarioHealth Corp.

    SC 13G - DarioHealth Corp. (0001533998) (Subject)

    12/13/24 4:05:12 PM ET
    $DRIO
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by PSQ Holdings Inc.

    SC 13G - PSQ Holdings, Inc. (0001847064) (Subject)

    12/12/24 11:50:43 AM ET
    $PSQH
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Verrica Pharmaceuticals Inc.

    SC 13G/A - Verrica Pharmaceuticals Inc. (0001660334) (Subject)

    12/9/24 6:22:49 PM ET
    $VRCA
    Biotechnology: Pharmaceutical Preparations
    Health Care